Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)
Stifel: Maintaining the MEI Pharma (MEIP.US) rating, adjusted from holding to holding rating, and adjusting the target price from $7.00 to $7.00.
MEI Pharma Analyst Ratings
Stifel Maintains Hold on MEI Pharma, Maintains $7 Price Target
MEI Pharma Analyst Ratings
Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)
Stifel Maintains Hold on MEI Pharma, Lowers Price Target to $9
MEI Pharma Analyst Ratings
Stifel Nicolaus Sticks to Its Hold Rating for MEI Pharma (MEIP)
Brookline Capital Maintains Buy on MEI Pharma, Announces $80 Price Target
Watching MEI Pharma; Hearing Brookline Capital Reiterates Buy Rating, $80 Price Target
Stifel Adjusts MEI Pharma's Price Target to $10 From $0.50, Keeps Hold Rating
BTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP)
HC Wainwright Adjusts Price Target on MEI Pharma to $2 From $5, Maintains Buy Rating
Stifel Nicolaus Adjusts MEI Pharma Price Target to $0.50 From $2, Maintains Hold Rating
MEI Pharma Analyst Ratings
HC Wainwright & Co. Maintains Buy on MEI Pharma, Lowers Price Target to $2
Brookline Capital Markets Reaffirms Their Buy Rating on MEI Pharma (MEIP)
MEI Pharma Analyst Ratings
Jefferies Downgrades MEI Pharma to Underperform, Lowers Price Target to $0.1
No Data